Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
Johnson & Johnson (NYSE: JNJ) has announced its upcoming first-quarter results investor conference call, scheduled for Tuesday, April 15th at 8:30 a.m. (Eastern Time). The call will be hosted by key executives including Joaquin Duato (Chairman and CEO), Joseph J. Wolk (CFO), and Jessica Moore (VP, Investor Relations).
Investors can access the call through two channels: via webcast at www.investor.jnj.com or by telephone. U.S. participants can dial 877-869-3847, while international participants should use 201-689-8261. A replay will be available until April 30th, with U.S. replay number 877-660-6853 and international replay number 201-612-7415 (Conference ID: 13752088).
The earnings press release will be available at 6:45 a.m. ET on the day of the call. The company has also noted its second-quarter earnings call is planned for Wednesday, July 16th, 2025.
Johnson & Johnson (NYSE: JNJ) ha annunciato la sua prossima conferenza telefonica per i risultati del primo trimestre, programmata per martedì 15 aprile alle 8:30 (ora orientale). La chiamata sarà condotta da importanti dirigenti tra cui Joaquin Duato (Presidente e CEO), Joseph J. Wolk (CFO) e Jessica Moore (VP, Relazioni con gli Investitori).
Gli investitori possono accedere alla chiamata attraverso due canali: via webcast su www.investor.jnj.com o telefonicamente. I partecipanti statunitensi possono comporre il numero 877-869-3847, mentre i partecipanti internazionali dovrebbero utilizzare il numero 201-689-8261. Una registrazione sarà disponibile fino al 30 aprile, con il numero di registrazione statunitense 877-660-6853 e il numero di registrazione internazionale 201-612-7415 (ID Conferenza: 13752088).
Il comunicato stampa sugli utili sarà disponibile alle 6:45 ET il giorno della chiamata. L'azienda ha anche informato che la chiamata sugli utili del secondo trimestre è prevista per mercoledì 16 luglio 2025.
Johnson & Johnson (NYSE: JNJ) ha anunciado su próxima conferencia telefónica de resultados del primer trimestre, programada para el martes 15 de abril a las 8:30 a.m. (hora del este). La llamada será conducida por ejecutivos clave, incluyendo a Joaquin Duato (Presidente y CEO), Joseph J. Wolk (CFO) y Jessica Moore (VP, Relaciones con Inversores).
Los inversores pueden acceder a la llamada a través de dos canales: por webcast en www.investor.jnj.com o por teléfono. Los participantes de EE. UU. pueden marcar el 877-869-3847, mientras que los participantes internacionales deben usar el 201-689-8261. Habrá una repetición disponible hasta el 30 de abril, con el número de repetición de EE. UU. 877-660-6853 y el número de repetición internacional 201-612-7415 (ID de Conferencia: 13752088).
El comunicado de prensa sobre las ganancias estará disponible a las 6:45 a.m. ET el día de la llamada. La empresa también ha señalado que su llamada sobre las ganancias del segundo trimestre está programada para el miércoles 16 de julio de 2025.
존슨 앤 존슨 (NYSE: JNJ)은 4월 15일 화요일 오전 8시 30분(동부 표준시)에 예정된 첫 분기 실적 투자자 컨퍼런스 콜을 발표했습니다. 이 전화 회의는 호아킨 두아토 (회장 겸 CEO), 조셉 J. 울크 (CFO), 제시카 무어 (부사장, 투자자 관계) 등 주요 경영진이 진행합니다.
투자자들은 두 가지 경로를 통해 전화 회의에 접속할 수 있습니다: www.investor.jnj.com을 통한 웹캐스트 또는 전화로. 미국 참가자는 877-869-3847로 전화하면 되고, 국제 참가자는 201-689-8261을 사용해야 합니다. 재생은 4월 30일까지 가능하며, 미국 재생 번호는 877-660-6853, 국제 재생 번호는 201-612-7415입니다 (회의 ID: 13752088).
실적 보도 자료는 전화 회의 당일 오전 6시 45분 ET에 제공될 예정입니다. 회사는 또한 2025년 7월 16일 수요일에 예정된 두 번째 분기 실적 전화 회의가 있다고 언급했습니다.
Johnson & Johnson (NYSE: JNJ) a annoncé sa prochaine conférence téléphonique sur les résultats du premier trimestre, prévue pour le mardi 15 avril à 8h30 (heure de l'Est). L'appel sera animé par des dirigeants clés, dont Joaquin Duato (Président et CEO), Joseph J. Wolk (CFO) et Jessica Moore (VP, Relations Investisseurs).
Les investisseurs peuvent accéder à l'appel par deux canaux : via le webinaire à www.investor.jnj.com ou par téléphone. Les participants américains peuvent composer le 877-869-3847, tandis que les participants internationaux doivent utiliser le 201-689-8261. Un enregistrement sera disponible jusqu'au 30 avril, avec le numéro d'enregistrement américain 877-660-6853 et le numéro d'enregistrement international 201-612-7415 (ID de conférence : 13752088).
Le communiqué de presse sur les résultats sera disponible à 6h45 ET le jour de l'appel. L'entreprise a également noté que sa conférence téléphonique sur les résultats du deuxième trimestre est prévue pour le mercredi 16 juillet 2025.
Johnson & Johnson (NYSE: JNJ) hat seine bevorstehende Telefonkonferenz zu den Ergebnissen des ersten Quartals angekündigt, die für Dienstag, den 15. April, um 8:30 Uhr (Eastern Time) geplant ist. Die Konferenz wird von wichtigen Führungskräften geleitet, darunter Joaquin Duato (Vorsitzender und CEO), Joseph J. Wolk (CFO) und Jessica Moore (VP, Investor Relations).
Investoren können die Konferenz über zwei Kanäle erreichen: entweder über das Webcast auf www.investor.jnj.com oder telefonisch. US-Teilnehmer können die Nummer 877-869-3847 wählen, während internationale Teilnehmer die 201-689-8261 verwenden sollten. Eine Aufzeichnung wird bis zum 30. April verfügbar sein, mit der US-Aufzeichnungsnummer 877-660-6853 und der internationalen Aufzeichnungsnummer 201-612-7415 (Konferenz-ID: 13752088).
Die Pressemitteilung zu den Ergebnissen wird am Tag der Konferenz um 6:45 Uhr ET verfügbar sein. Das Unternehmen hat auch darauf hingewiesen, dass die Telefonkonferenz zu den Ergebnissen des zweiten Quartals für Mittwoch, den 16. Juli 2025, geplant ist.
- None.
- None.
Investors and other interested parties can access the webcast/conference call in the following ways:
- The webcast and presentation material are accessible at Johnson & Johnson’s website www.investor.jnj.com. A replay of the webcast will be available approximately three hours after the conference call concludes.
-
By telephone: for both “listen-only” participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the
U.S. is 877-869-3847. For participants outside theU.S. , the dial-in number is 201-689-8261. -
A replay of the conference call will be available until approximately 12:00 a.m. on April 30th. The replay dial-in number for
U.S. participants is 877-660-6853. For participants outside theU.S. , the replay dial-in number is 201-612-7415. The replay conference ID number for all callers is 13752088. - The press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call.
- Please refer to www.investor.jnj.com for a complete list of currently planned earnings webcast/conference calls. Please note the second-quarter date of Wednesday, July 16th, 2025.
About Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250305476174/en/
Media
media-relations@its.jnj.com
Investor:
investor-relations@its.jnj.com
Source: Johnson & Johnson
FAQ
When is Johnson & Johnson (JNJ) releasing its Q1 2024 earnings results?
How can investors access JNJ's Q1 2024 earnings call?
Who will be presenting at Johnson & Johnson's Q1 2024 earnings call?
Until when will JNJ's Q1 2024 earnings call replay be available?
